China Bismuth Subsalicylate Gains 1.10% in June 2026 Amid Tight Feedstock Supply

China bismuth subsalicylate prices rose 1.10% in June 2026 as constrained upstream raw-material flows, and firmer pharmaceutical demand supported a modest seller-led move. Early June saw concentrate inflows to Guangxi and Hunan smelters tighten, keeping refined bismuth subsalicylate output essentially flat and pushing procurement premiums higher. Mid-month, steady operating rates coincided with stringent mid-year environmental inspections that limited operating flexibility, while late-month hospital procurement cycles and expanded e-commerce pharmacy sales ahead of the summer travel season allowed sellers to maintain a slightly bullish stance. These dynamics combined to lift June averages for bismuth subsalicylate, according to ChemAnalyst data.

Pharmaceutical demand was the dominant driver through the month. The gastrointestinal formulations segment remained strong, supported by provincial hospital tenders that were settled during the quarter and by increased e-commerce pharmacy activity; export bookings to India and the United States also stayed firm, underpinning bismuth subsalicylate volumes. In contrast, import inquiries from markets such as Brazil and Indonesia held steady rather than accelerating, providing no offset to the domestic strength. Per ChemAnalyst data, the average spot price for bismuth subsalicylate edged 1.10% above the May close as constrained concentrate supply and healthier offtake provided sellers with room to pass through modest increases.

On the supply side, rising procurement premiums for bismuth concentrates and refined bismuth metal pushed marginal production costs higher, keeping refined bismuth subsalicylate output flat and limiting inventory build-up. Meanwhile, salicylic acid availability and pricing remained stable, offering partial relief to producers and preventing a sharper rise in cost inflation. Geopolitical risk to crude and derivative streams — notably benzene and propylene that feed phenol and salicylic acid production — represents a contingency that could widen producers’ cost base if disrupted. No major maintenance outages were reported in June, but mid-year environmental inspections further constrained operating flexibility, per ChemAnalyst data on bismuth subsalicylate.

Price movement within June was orderly rather than volatile: tightened concentrate receipts early in the month set a firmer tenor, mid-month operating steadiness kept markets supportive, and late-month tender and retail activity allowed sellers to pass through modest increases. Logistics on the Yangtze and coastal rail corridors functioned smoothly, enabling timely export dispatches from Shanghai and preventing accumulation of backlogs that might otherwise have dampened the bismuth subsalicylate market. Overall, the market traded within a narrow upward band rather than experiencing abrupt swings, per our analysts’ assessment.

Looking ahead, ChemAnalyst analysis points to a mixed trajectory for bismuth subsalicylate in the second half of 2026 as availability and cost of bismuth concentrates, export restocking patterns and ongoing regulatory inspections determine the pace of movement. Forecasts through December show alternating modest declines and gains, driven largely by feedstock availability and seasonal export demand for bismuth subsalicylate. This outlook is based on current market trends and remains subject to market conditions, including any change in concentrate receipts or upstream cost pressures.